Holen Sie sich die Stockscreener-App
5.195
2.78%
0.155
Schlusskurs vom Vortag:
$5.04
Offen:
$5.1
24-Stunden-Volumen:
182.11K
Relative Volume:
0.31
Marktkapitalisierung:
$1.62B
Einnahmen:
$391.87M
Nettoeinkommen (Verlust:
$-441.45M
KGV:
-2.8081
EPS:
-1.85
Netto-Cashflow:
$-301.21M
1W Leistung:
+4.65%
1M Leistung:
+4.86%
6M Leistung:
-40.32%
1J Leistung:
-61.02%
1-Tages-Spanne:
$5.10
$5.255
1-Wochen-Bereich:
$4.75
$5.255
52-Wochen-Spanne:
$4.32
$13.40
Alvotech Stock (ALVO) Company Profile
Vergleichen Sie ALVO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ALVO
Alvotech
|
5.19 | 1.57B | 391.87M | -441.45M | -301.21M | -1.85 |
|
ZTS
Zoetis Inc
|
124.05 | 55.12B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.97 | 50.80B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
10.27 | 45.60B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.65 | 36.04B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
UTHR
United Therapeutics Corp
|
470.62 | 20.23B | 3.08B | 1.24B | 1.07B | 25.61 |
Alvotech Stock (ALVO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-09 | Eingeleitet | Barclays | Underweight |
| 2025-11-04 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2025-10-14 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2025-09-23 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2025-02-14 | Eingeleitet | UBS | Buy |
| 2024-01-29 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2023-10-20 | Hochstufung | Citigroup | Sell → Neutral |
| 2023-09-21 | Eingeleitet | Barclays | Equal Weight |
| 2022-09-07 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2022-09-06 | Herabstufung | Citigroup | Buy → Sell |
| 2022-07-26 | Eingeleitet | Citigroup | Buy |
Alle ansehen
Alvotech Aktie (ALVO) Neueste Nachrichten
Alvotech: Why FDA Delays Don't Break The Bull Case (NASDAQ:ALVO) - Seeking Alpha
ALVO Investor News: If You Have Suffered Losses in Alvotech (NASDAQ: ALVO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights - GlobeNewswire Inc.
Aug Fed Impact: Can Alvotech Equity Warrant be recession proofQuarterly Profit Review & AI Enhanced Trading Signals - baoquankhu1.vn
Assessing Alvotech (ALVO) Valuation After FDA Setback And Securities Investigation Concerns - simplywall.st
Rosen Law Firm Encourages Alvotech Investors to Inquire About Se - GuruFocus
Is Alvotech the Sleeper Stock of the Year or Just Overhyped Noise? - AD HOC NEWS
ETF Watch: Is Alvotech Equity Warrant stock a smart retirement pickPortfolio Performance Report & Free Real-Time Market Sentiment Alerts - baoquankhu1.vn
ALVO Investor News: If You Have Suffered Losses in Alvotech - GlobeNewswire
Retail Trends: Is HLVX likely to announce a buyback2025 Momentum Check & Community Trade Idea Sharing Platform - baoquankhu1.vn
Alvotech Faces Securities Claims After 34% Stock Drop Due to Misleading Information - Intellectia AI
Published on: 2026-01-16 12:28:06 - baoquankhu1.vn
Patterns Watch: Is Alvotech Equity Warrant stock forming a triangle patternPortfolio Update Report & Free Growth Oriented Trading Recommendations - baoquankhu1.vn
Buybacks Report: Whats the fair value of Alvotech stock2025 Top Decliners & Growth Focused Entry Point Reports - baoquankhu1.vn
ALVO INVESTOR ALERT: Hagens Berman Investigates Alvotech (ALVO) for Potential Securities Fraud Following Massive FDA-Induced Stock Crash - Sahm
Rosen Law Firm Encourages Alvotech Investors to Inquire About Securities Class Action InvestigationALVO - Sahm
Alvotech (ALVO) Faces Investigation After 34% Stock Drop Following FDA Complete Response Letter - Intellectia AI
Bragar Eagel & Squire, P.C. Continues Investigations into Alvotech and Beyond Meat on Behalf of Stockholders and Encourages Investors to Contact the Firm - GlobeNewswire
Alvotech (ALVO) Valuation Check As New $100 Million Loan Supports Biosimilar Launch Plans - simplywall.st
Alvotech (ALVO) Announces a Commercialization Agreement With Advanz Pharma - MSN
Alvotech (ALVO) Stock Analysis: Unpacking A Potential 349.63% Upside - DirectorsTalk Interviews
Portfolio Recap: Will Alvotech stock gain from strong economyGold Moves & Safe Capital Growth Plans - moha.gov.vn
ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Gauzy Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
Aug Final Week: Can Alvotech Equity Warrant sustain its profitabilityAnalyst Upgrade & Real-Time Market Trend Scan - baoquankhu1.vn
Alvotech (ALVO) secures $100 million in new financing - MSN
Alvotech Investor News: Rosen Law Firm Encourages Alvotech Investors to Inquire About Securities Class Action InvestigationALVO - Cherokee Tribune
Alvotech (NASDAQ:ALVO) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
Alvotech announces European launch of biosimilar to Simponi - MSN
Alvotech’s Gobivaz Biosimilar Gains UK Approval - MSN
Alvotech Faces Securities Claims Investigation After 34% Stock Drop - Intellectia AI
Alvotech Investor News: Rosen Law Firm Encourages Alvotech Inves - GuruFocus
Alvotech and Dr. Reddy’s gets FDA nod for Biologic License Application for AVT03 - MSN
ALVO Investor News: If You Have Suffered Losses in Alvotech (NASDAQ: ALVO), You Are Encouraged ... - Bluefield Daily Telegraph
Alvotech (ALVO) Faces Investor Scrutiny Amid Manufacturing Deficiencies Severely Impacting Assurances of 2025 Revenues and Adjusted EBITDA, Stock Tumbles 33% -- Hagens Berman - Eastern Progress
Alvotech (ALVO) Secures $100 Million in New Financing - Finviz
Alvotech announces CEO transition - MSN
How Alvotech Equity Warrant stock reacts to job market data2025 EndofYear Setup & Risk Managed Investment Entry Signals - ulpravda.ru
Why Alvotech (ALVO) Is Down 7.8% After CEO Transition And Costly New Loan DealAnd What's Next - simplywall.st
Is Alvotech stock dividend yield sustainableJuly 2025 Earnings & Technical Pattern Recognition Alerts - ulpravda.ru
Is Alvotech Equity Warrant stock a contrarian buyQuarterly Profit Summary & Expert Approved Trade Ideas - ulpravda.ru
Will Alvotech (Z45) stock return to pre crash levelsMarket Growth Review & Advanced Swing Trade Entry Alerts - ulpravda.ru
Alvotech (ALVO): Firm reaffirms 2025 growth outlook - MSN
Alvotech (ALVO) Stock Price History & Data - Traders Union
Is Alvotech Equity Warrant stock a dividend growth opportunityBreakout Watch & Accurate Technical Buy Alerts - ulpravda.ru
How Alvotech (Z45) stock correlates with oil marketsMarket Weekly Review & Daily Price Action Insights - ulpravda.ru
Why Alvotech stock is a must watch in 2025July 2025 Momentum & Weekly Momentum Stock Picks - ulpravda.ru
How Alvotech stock performs in weak economyTrade Risk Assessment & AI Forecast Swing Trade Picks - ulpravda.ru
Operating margin % of Alvotech – BX:ALVOUSD - TradingView — Track All Markets
Current ratio of Alvotech – BX:ALVOUSD - TradingView — Track All Markets
Free cash flow per share of Alvotech – BX:ALVOUSD - TradingView — Track All Markets
Operating expenses (excl. COGS) of Alvotech – BX:ALVOUSD - TradingView — Track All Markets
Alvotech Earnings and Revenue – BX:ALVOUSD - TradingView — Track All Markets
Finanzdaten der Alvotech-Aktie (ALVO)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):